(Q37841572)

English

Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy

scientific article published on February 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Emmanuel J Favaloro

4

object named as

Emmanuel J Favaloro

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1

object named as

Giuseppe Lippi

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Massimo Franchini

5

object named as

Massimo Franchini

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Martina Montagnana

2

object named as

Martina Montagnana

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

3

object named as

Elisa Danese

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Biomarkers in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

63-70

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

An Abnormal Platelet Glycoprotein Pattern in Three Cases of Glanzmann's Thrombasthenia

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Organization of the gene for platelet glycoprotein IIb.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Bi-directional signal transduction by integrin receptors

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Glycoprotein Ib-IX-mediated activation of integrin alpha(IIb)beta(3): effects of receptor clustering and von Willebrand factor adhesion

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

The integrin alpha IIb/beta 3 in human platelet signal transduction

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Structure of an integrin IIb 3 transmembrane-cytoplasmic heterocomplex provides insight into integrin activation

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

A redox site involved in integrin activation

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Mechanism of integrin activation by disulfide bond reduction

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Rationally designed integrin beta3 mutants stabilized in the high affinity conformation

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Control of integrin alphaIIb beta3 outside-in signaling and platelet adhesion by sensing the physical properties of fibrin(ogen) substrates

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Proteomic analysis of integrin alphaIIbbeta3 outside-in signaling reveals Src-kinase-independent phosphorylation of Dok-1 and Dok-3 leading to SHIP-1 interactions

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

New antiplatelet agents: why they are needed

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Basic principles of platelet biology and clinical implications

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Clinical aspects of platelet inhibitors and thrombus formation

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitors

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST t

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Long-term treatment with a platelet glycoprotein-receptor antagonist after percutaneous coronary revascularization. EXCITE Trial Investigators. Evaluation of Oral Xemilofiban in Controlling Thrombotic Events

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trials

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Contemporary platelet function testing

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Clinical utility of the PFA-100.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Variable response to the biological inhibition of platelets by abciximab in patients subjected to percutaneous coronary angioplasty

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Rapid assessment of glycoprotein IIb/IIIa blockade with the platelet function analyzer (PFA-100) during percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Determination of platelet aggregation inhibition during percutaneous coronary intervention with the platelet function analyzer PFA-100

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reop

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Monitoring platelet function in glycoprotein IIB/IIIA inhibitor therapy

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Genetic and acquired determinants of individual variability of response to antiplatelet drugs

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Laboratory assessment and perioperative management of patients on antiplatelet therapy: from the bench to the bedside

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Screening tests of platelet function: update on their appropriate uses for diagnostic testing

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Diagnostic assessment of platelet disorders: what are the challenges to standardization?

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (I

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Measuring antiplatelet drug effects in the laboratory

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Platelet function tests and flow cytometry to monitor antiplatelet therapy

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study.

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Platelet GPIIb-IIIa blockers

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Antiplatelet drugs

1 reference

https://api.crossref.org/works/10.2217%2FBMM.10.119

21 January 2018

Identifiers

10.2217/BMM.10.119

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

release_tmxgliqffbesvblteha76potyu

1 reference

https://api.fatcat.wiki/v0/release/tmxgliqffbesvblteha76potyu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37841572&oldid=2110196155"